14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.24 $2.30 Wednesday, 24th Apr 2024 ATOS stock ended at $1.50. This is 0.671% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 7.77% from a day low at $1.48 to a day high of $1.60.
90 days $0.774 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Apr 24, 2024 $1.48 $1.60 $1.48 $1.50 1 852 961
Apr 23, 2024 $1.41 $1.51 $1.41 $1.49 1 140 053
Apr 22, 2024 $1.32 $1.47 $1.32 $1.42 1 018 581
Apr 19, 2024 $1.43 $1.43 $1.33 $1.37 1 171 650
Apr 18, 2024 $1.31 $1.48 $1.24 $1.42 2 317 498
Apr 17, 2024 $1.54 $1.62 $1.35 $1.35 4 051 374
Apr 16, 2024 $1.67 $1.69 $1.53 $1.54 1 704 648
Apr 15, 2024 $1.63 $1.73 $1.63 $1.71 1 600 811
Apr 12, 2024 $1.83 $1.83 $1.60 $1.66 1 995 430
Apr 11, 2024 $1.77 $1.84 $1.74 $1.77 953 794
Apr 10, 2024 $1.79 $1.82 $1.72 $1.75 1 633 955
Apr 09, 2024 $1.76 $1.97 $1.70 $1.84 3 823 654
Apr 08, 2024 $1.85 $1.91 $1.63 $1.75 4 039 769
Apr 05, 2024 $2.17 $2.30 $1.60 $1.87 10 456 092
Apr 04, 2024 $2.04 $2.27 $2.03 $2.10 3 982 951
Apr 03, 2024 $1.84 $2.07 $1.81 $2.03 2 369 691
Apr 02, 2024 $2.00 $2.04 $1.82 $1.84 3 525 053
Apr 01, 2024 $1.84 $2.11 $1.78 $2.00 3 384 682
Mar 28, 2024 $1.85 $1.91 $1.76 $1.80 1 874 508
Mar 27, 2024 $1.82 $1.87 $1.70 $1.83 1 972 350
Mar 26, 2024 $1.92 $1.94 $1.72 $1.80 3 751 179
Mar 25, 2024 $1.65 $1.89 $1.61 $1.89 3 131 277
Mar 22, 2024 $1.70 $1.70 $1.57 $1.67 1 859 874
Mar 21, 2024 $1.65 $1.70 $1.57 $1.68 2 535 692
Mar 20, 2024 $1.62 $1.73 $1.53 $1.63 6 785 191
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT